Hepatitis B Vaccine Labels Show Generic Biologics Possible, GPhA Says

Labeling for GlaxoSmithKline's Engerix-B hepatitis B vaccine demonstrates the feasibility of "generic" biologics, Generic Pharmaceutical Association representative William Schultz told a June 23 Senate Judiciary Committee hearing on follow-on biologics